Benzo Discontinuation Improves Quality of Life and Reduces Symptoms of Schizophrenia

Kermit Cole

Researchers in Japan find that tapering or reducing benzodiazepines has a positive effect on quality of life, verbal and working memory, and psychiatric symptoms in people with a schizophrenia diagnosis, with no adverse effects. The study found that a daily dose reduction strategy of 25-50% per 2-4 weeks was safe. The study appears in the upcoming issue of Progress in Neuro-Psychopharmacology and Biological Psychiatry.
Read more
                          Discuss → 


Mad in America hosts blogs by a diverse group of writers. These posts are designed to serve as a public forum for a discussion—broadly speaking—of psychiatry and its treatments. The opinions expressed are the writers’ own.

Previous articleNon-Drug Therapies Outperform Drug Therapies in Preventing Relapse
Next articleChildhood Maltreatment Reduces Hippocampal Volume
Kermit Cole
Kermit Cole, MFT, founding editor of Mad in America, works in Santa Fe, New Mexico as a couples and family therapist. Inspired by Open Dialogue, he works as part of a team and consults with couples and families that have members identified as patients. His work in residential treatment — largely with severely traumatized and/or "psychotic" clients — led to an appreciation of the power and beauty of systemic philosophy and practice, as the alternative to the prevailing focus on individual pathology. A former film-maker, he has undergraduate and master's degrees in psychology from Harvard University, as well as an MFT degree from the Council for Relationships in Philadelphia. He is a doctoral candidate with the Taos Institute and the Free University of Brussels. You can reach him at [email protected]